Keensight Capital backs Cardiff-based CRO

Private equity growth buyout firm Keensight Capital has taken a stake in CatSci Ltd, a Cardiff-based contract research organisation (CRO) working with international pharmaceutical businesses. Financial details of the transaction have not been disclosed. CatSci was spun out of AstraZeneca’s Catalyst Screening Facility in 2010 by five founders – including current CEO Ross Burn and…

You must be a HM Subscriber to view this content.

Subscribe Now »